Panax notoginseng root extract induces nuclear translocation of CRTC1 and Bdnf mRNA expression in cortical neurons

• Published in: Drug discoveries & therapeutics
• Main Authors: Shimizu, Shunsuke, Nakano, Aoi, Ihara, Daisuke, Nakayama, Hironori, Jo, Michiko, Toume, Kazufumi, Komatsu, Katsuko, Shibahara, Naotoshi, Tsuda, Masaaki, Fukuchi, Mamoru, Tabuchi, Akiko
• Format: Journal Article
• Language: English
• Published: Japan 24.10.2024
• Subjects: BDNF; CRTC1; calcineurin; L-VDCC; Panax notoginseng root extract
• ISSN: 1881-784X

Brain-derived neurotrophic factor (BDNF), a member of the neurotrophin family, is deeply involved in the development and higher function of the nervous system, including learning and memory. By contrast, a reduction in BDNF levels is associated with various neurological disorders such as dementia and depression. Therefore, the inducers of Bdnf expression might be valuable in ameliorating or protecting against a decline in brain functions. We previously reported that, through high-throughput screening to identify inducers of Bdnf expression in Bdnf-luciferase transgenic mice, several herbal extracts induced Bdnf expression in cortical neurons. In the present study, we found that Panax notoginseng root extract (PNRE) potently induced Bdnf expression in primary cultured cortical neurons primarily via the L-type voltage-dependent Ca channel (L-VDCC) and calcineurin. PNRE promoted nuclear translocation of cAMP-responsive element-binding protein-regulated transcription coactivator 1 (CRTC1). These findings suggest that PNRE activates the L-VDCC/calcineurin/CRTC1 axis, which is the primary signaling pathway involved in the neuronal activity-dependent expression of Bdnf. Moreover, we demonstrated that PNRE increased the dendritic complexity of cortical neurons in vitro. Thus, by upregulating Bdnf expression, PNRE is a potential candidate for improving cognitive impairment seen in several kinds of dementia.